Astellas Teams Up With Cytokinetics To Develop Skeletal Muscle Activator
This article was originally published in PharmAsia News
Executive Summary
Astellas Pharmaceuticals entered into an agreement regarding the research, development, and commercialization of a skeletal muscle activator with U.S. firm Cytokinetics.